STOCK TITAN

[Form 4/A] Vertiv Holdings Co Amended Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4/A
Rhea-AI Filing Summary

InnovAge Holding Corp. (INNV) filed a Form 4 disclosing that director Edward M. Kennedy Jr. received 25,316 Restricted Stock Units (RSUs) on July 1, 2025. The award was recorded at a purchase price of $0 because RSUs are equity compensation rather than open-market purchases.

The RSUs will vest in full on June 30, 2026, provided the director remains in service through that date. Upon settlement, the units will convert into an equivalent number of common shares. Following the grant, Kennedy’s direct beneficial ownership totals 68,157 shares of InnovAge common stock.

No sales, option exercises, derivative positions, or other transactions were reported. The filing therefore reflects a routine equity-compensation grant that modestly increases insider alignment but does not involve immediate cash inflows, earnings information, or strategic developments.

InnovAge Holding Corp. (INNV) ha depositato un Modulo 4 comunicando che il direttore Edward M. Kennedy Jr. ha ricevuto 25.316 Unità Azionarie Vincolate (RSU) il 1° luglio 2025. Il premio è stato registrato con un prezzo di acquisto di 0 $ poiché le RSU rappresentano una forma di compensazione azionaria e non acquisti sul mercato aperto.

Le RSU matureranno completamente il 30 giugno 2026, a condizione che il direttore rimanga in servizio fino a tale data. Al momento della liquidazione, le unità si convertiranno in un numero equivalente di azioni ordinarie. Dopo l’assegnazione, la posizione diretta di proprietà di Kennedy ammonta a 68.157 azioni ordinarie di InnovAge.

Non sono state segnalate vendite, esercizi di opzioni, posizioni derivati o altre transazioni. Il deposito riflette quindi una normale assegnazione di compensazione azionaria che aumenta moderatamente l’allineamento degli insider, senza coinvolgere flussi di cassa immediati, informazioni sugli utili o sviluppi strategici.

InnovAge Holding Corp. (INNV) presentó un Formulario 4 revelando que el director Edward M. Kennedy Jr. recibió 25,316 Unidades de Acciones Restringidas (RSU) el 1 de julio de 2025. La concesión fue registrada con un precio de compra de $0 porque las RSU son una compensación en acciones y no compras en el mercado abierto.

Las RSU se consolidarán por completo el 30 de junio de 2026, siempre que el director permanezca en servicio hasta esa fecha. Al momento de la liquidación, las unidades se convertirán en un número equivalente de acciones comunes. Tras la concesión, la propiedad directa de Kennedy suma 68,157 acciones comunes de InnovAge.

No se reportaron ventas, ejercicios de opciones, posiciones derivadas ni otras transacciones. Por lo tanto, la presentación refleja una concesión rutinaria de compensación en acciones que aumenta modestamente la alineación de los insiders, pero no implica entradas de efectivo inmediatas, información sobre ganancias ni desarrollos estratégicos.

InnovAge Holding Corp. (INNV)는 이사 Edward M. Kennedy Jr.2025년 7월 1일25,316개의 제한 주식 단위(RSU)를 받았음을 공개하는 Form 4를 제출했습니다. 이 수여는 RSU가 공개 시장에서의 구매가 아닌 주식 보상 형태이기 때문에 구매 가격 $0로 기록되었습니다.

RSU는 이사가 해당 날짜까지 재직하는 경우 2026년 6월 30일에 전액 취득됩니다. 정산 시 단위는 동일한 수의 보통주로 전환됩니다. 수여 후 케네디의 직접 소유 주식은 InnovAge 보통주 68,157주에 달합니다.

판매, 옵션 행사, 파생상품 포지션 또는 기타 거래는 보고되지 않았습니다. 따라서 이번 제출은 내부자 정렬을 소폭 높이는 일상적인 주식 보상 수여를 반영하며 즉각적인 현금 유입, 수익 정보 또는 전략적 발전과는 관련이 없습니다.

InnovAge Holding Corp. (INNV) a déposé un formulaire 4 révélant que le directeur Edward M. Kennedy Jr. a reçu 25 316 unités d’actions restreintes (RSU) le 1er juillet 2025. Cette attribution a été enregistrée à un prix d’achat de 0 $ car les RSU constituent une rémunération en actions et non des achats sur le marché libre.

Les RSU seront entièrement acquises le 30 juin 2026, à condition que le directeur reste en fonction jusqu’à cette date. Lors du règlement, les unités seront converties en un nombre équivalent d’actions ordinaires. Après cette attribution, la possession directe de Kennedy s’élève à 68 157 actions ordinaires d’InnovAge.

Aucune vente, exercice d’options, position dérivée ou autre transaction n’a été signalée. Le dépôt reflète donc une attribution de rémunération en actions de routine qui augmente modestement l’alignement des initiés sans impliquer d’entrées de trésorerie immédiates, d’informations sur les bénéfices ou de développements stratégiques.

InnovAge Holding Corp. (INNV) reichte ein Formular 4 ein, in dem offengelegt wird, dass der Direktor Edward M. Kennedy Jr. am 1. Juli 2025 25.316 Restricted Stock Units (RSUs) erhalten hat. Die Zuteilung wurde mit einem Kaufpreis von 0 $ verbucht, da RSUs eine Aktienvergütung und kein Kauf am offenen Markt darstellen.

Die RSUs werden am 30. Juni 2026 vollständig vesten, vorausgesetzt, der Direktor bleibt bis zu diesem Datum im Dienst. Bei der Abrechnung werden die Einheiten in eine entsprechende Anzahl Stammaktien umgewandelt. Nach der Gewährung beträgt Kennedys direkter Eigentumsanteil an InnovAge-Stammaktien 68.157 Aktien.

Es wurden keine Verkäufe, Optionsausübungen, Derivatpositionen oder andere Transaktionen gemeldet. Die Einreichung spiegelt daher eine routinemäßige Aktienvergütung wider, die die Insider-Ausrichtung leicht erhöht, jedoch keine sofortigen Geldzuflüsse, Gewinninformationen oder strategische Entwicklungen beinhaltet.

Positive
  • Director’s beneficial ownership increases by 25,316 shares, incrementally aligning insider and shareholder interests.
Negative
  • RSU grant creates potential future dilution once shares vest, though impact is expected to be minor.
  • No open-market purchase; therefore, the filing offers limited positive signaling about management’s view of the stock’s value.

Insights

TL;DR: Routine RSU grant; neutral impact, modestly improves alignment, negligible dilution until vesting.

The award of 25,316 RSUs to Director Edward M. Kennedy Jr. is standard board compensation. Because the units vest in 2026 and were issued at no cost, the grant only potentially dilutes shareholders after vesting and has no near-term P&L or cash impact. Insider ownership rises to 68,157 shares, incrementally strengthening incentive alignment, but the size is immaterial relative to InnovAge’s overall float. With no accompanying purchases, sales, or performance commentary, I view the filing as administratively routine and neutral for valuation.

InnovAge Holding Corp. (INNV) ha depositato un Modulo 4 comunicando che il direttore Edward M. Kennedy Jr. ha ricevuto 25.316 Unità Azionarie Vincolate (RSU) il 1° luglio 2025. Il premio è stato registrato con un prezzo di acquisto di 0 $ poiché le RSU rappresentano una forma di compensazione azionaria e non acquisti sul mercato aperto.

Le RSU matureranno completamente il 30 giugno 2026, a condizione che il direttore rimanga in servizio fino a tale data. Al momento della liquidazione, le unità si convertiranno in un numero equivalente di azioni ordinarie. Dopo l’assegnazione, la posizione diretta di proprietà di Kennedy ammonta a 68.157 azioni ordinarie di InnovAge.

Non sono state segnalate vendite, esercizi di opzioni, posizioni derivati o altre transazioni. Il deposito riflette quindi una normale assegnazione di compensazione azionaria che aumenta moderatamente l’allineamento degli insider, senza coinvolgere flussi di cassa immediati, informazioni sugli utili o sviluppi strategici.

InnovAge Holding Corp. (INNV) presentó un Formulario 4 revelando que el director Edward M. Kennedy Jr. recibió 25,316 Unidades de Acciones Restringidas (RSU) el 1 de julio de 2025. La concesión fue registrada con un precio de compra de $0 porque las RSU son una compensación en acciones y no compras en el mercado abierto.

Las RSU se consolidarán por completo el 30 de junio de 2026, siempre que el director permanezca en servicio hasta esa fecha. Al momento de la liquidación, las unidades se convertirán en un número equivalente de acciones comunes. Tras la concesión, la propiedad directa de Kennedy suma 68,157 acciones comunes de InnovAge.

No se reportaron ventas, ejercicios de opciones, posiciones derivadas ni otras transacciones. Por lo tanto, la presentación refleja una concesión rutinaria de compensación en acciones que aumenta modestamente la alineación de los insiders, pero no implica entradas de efectivo inmediatas, información sobre ganancias ni desarrollos estratégicos.

InnovAge Holding Corp. (INNV)는 이사 Edward M. Kennedy Jr.2025년 7월 1일25,316개의 제한 주식 단위(RSU)를 받았음을 공개하는 Form 4를 제출했습니다. 이 수여는 RSU가 공개 시장에서의 구매가 아닌 주식 보상 형태이기 때문에 구매 가격 $0로 기록되었습니다.

RSU는 이사가 해당 날짜까지 재직하는 경우 2026년 6월 30일에 전액 취득됩니다. 정산 시 단위는 동일한 수의 보통주로 전환됩니다. 수여 후 케네디의 직접 소유 주식은 InnovAge 보통주 68,157주에 달합니다.

판매, 옵션 행사, 파생상품 포지션 또는 기타 거래는 보고되지 않았습니다. 따라서 이번 제출은 내부자 정렬을 소폭 높이는 일상적인 주식 보상 수여를 반영하며 즉각적인 현금 유입, 수익 정보 또는 전략적 발전과는 관련이 없습니다.

InnovAge Holding Corp. (INNV) a déposé un formulaire 4 révélant que le directeur Edward M. Kennedy Jr. a reçu 25 316 unités d’actions restreintes (RSU) le 1er juillet 2025. Cette attribution a été enregistrée à un prix d’achat de 0 $ car les RSU constituent une rémunération en actions et non des achats sur le marché libre.

Les RSU seront entièrement acquises le 30 juin 2026, à condition que le directeur reste en fonction jusqu’à cette date. Lors du règlement, les unités seront converties en un nombre équivalent d’actions ordinaires. Après cette attribution, la possession directe de Kennedy s’élève à 68 157 actions ordinaires d’InnovAge.

Aucune vente, exercice d’options, position dérivée ou autre transaction n’a été signalée. Le dépôt reflète donc une attribution de rémunération en actions de routine qui augmente modestement l’alignement des initiés sans impliquer d’entrées de trésorerie immédiates, d’informations sur les bénéfices ou de développements stratégiques.

InnovAge Holding Corp. (INNV) reichte ein Formular 4 ein, in dem offengelegt wird, dass der Direktor Edward M. Kennedy Jr. am 1. Juli 2025 25.316 Restricted Stock Units (RSUs) erhalten hat. Die Zuteilung wurde mit einem Kaufpreis von 0 $ verbucht, da RSUs eine Aktienvergütung und kein Kauf am offenen Markt darstellen.

Die RSUs werden am 30. Juni 2026 vollständig vesten, vorausgesetzt, der Direktor bleibt bis zu diesem Datum im Dienst. Bei der Abrechnung werden die Einheiten in eine entsprechende Anzahl Stammaktien umgewandelt. Nach der Gewährung beträgt Kennedys direkter Eigentumsanteil an InnovAge-Stammaktien 68.157 Aktien.

Es wurden keine Verkäufe, Optionsausübungen, Derivatpositionen oder andere Transaktionen gemeldet. Die Einreichung spiegelt daher eine routinemäßige Aktienvergütung wider, die die Insider-Ausrichtung leicht erhöht, jedoch keine sofortigen Geldzuflüsse, Gewinninformationen oder strategische Entwicklungen beinhaltet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Giresi Michael

(Last) (First) (Middle)
C/O VERTIV HOLDINGS CO
505 N. CLEVELAND AVE

(Street)
WESTERVILLE OH 43082

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vertiv Holdings Co [ VRT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Information Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
07/01/2025
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options $128.41 06/30/2025 A 6,657 (1) 06/30/2035(2) Class A Common Stock 6,657 $0 6,657 D
Explanation of Responses:
1. The stock options will vest as to 25% on each of the first four anniversaries of July 15, 2025.
2. This line item is being re-reported from a previously filed Form 4 filed on July 1, 2025 to amend a clerical error in the expiration date of the stock option award to the correct date of June 30, 2035, as stated herein.
Remarks:
/s/ Robert M. Wolfe, as attorney-in-fact 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did InnovAge (INNV) report on Form 4?

Director Edward M. Kennedy Jr. was granted 25,316 Restricted Stock Units on July 1, 2025.

When will the RSUs granted to Edward M. Kennedy Jr. vest?

The RSUs will vest in full on June 30, 2026, subject to continued service.

How many InnovAge shares does Kennedy own after the transaction?

His total direct beneficial ownership is 68,157 common shares following the grant.

Did the Form 4 disclose any stock sales or option exercises?

No. The filing only reported an RSU grant; there were no sales or option exercises.

Was any cash paid for the RSUs?

No. RSUs are issued at $0 purchase price as part of equity-based compensation.
Vertiv Holdings Co

NYSE:VRT

VRT Rankings

VRT Latest News

VRT Latest SEC Filings

VRT Stock Data

47.18B
379.46M
0.9%
84.1%
2.6%
Electrical Equipment & Parts
Electronic Components, Nec
Link
United States
WESTERVILLE